PortfoliosLab logoPortfoliosLab logo
AGL vs. AORT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AGL vs. AORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in agilon health, inc. (AGL) and Artivion, Inc. (AORT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AGL achieves a 403.85% return, which is significantly higher than AORT's -55.23% return.


AGL

1D
-6.26%
1M
193.27%
YTD
403.85%
6M
425.68%
1Y
54.22%
3Y*
-44.43%
5Y*
-37.59%
10Y*

AORT

1D
-2.99%
1M
-43.61%
YTD
-55.23%
6M
-54.99%
1Y
-28.87%
3Y*
10.12%
5Y*
-6.59%
10Y*
5.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AGL vs. AORT - Yearly Performance Comparison


2026 (YTD)20252024202320222021
AGL
agilon health, inc.
403.85%-63.75%-84.86%-22.24%-40.22%-12.90%
AORT
Artivion, Inc.
-55.23%59.53%59.90%47.52%-40.44%-10.15%

Correlation

The correlation between AGL and AORT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Apr 16, 2021

0.21

Fundamentals

Market Cap

AGL:

$1.45B

AORT:

$1.02B

EPS

AGL:

-$22.51

AORT:

$0.24

PS Ratio

AGL:

0.25

AORT:

2.15

PB Ratio

AGL:

7.97

AORT:

2.25

Total Revenue (TTM)

AGL:

$5.82B

AORT:

$458.69M

Gross Profit (TTM)

AGL:

-$225.14M

AORT:

$292.61M

EBITDA (TTM)

AGL:

-$340.64M

AORT:

$53.91M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AGL vs. AORT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AGL
AGL Risk / Return Rank: 6161
Overall Rank
AGL Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
AGL Sortino Ratio Rank: 7373
Sortino Ratio Rank
AGL Omega Ratio Rank: 7575
Omega Ratio Rank
AGL Calmar Ratio Rank: 5454
Calmar Ratio Rank
AGL Martin Ratio Rank: 5151
Martin Ratio Rank

AORT
AORT Risk / Return Rank: 1515
Overall Rank
AORT Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
AORT Sortino Ratio Rank: 1818
Sortino Ratio Rank
AORT Omega Ratio Rank: 1515
Omega Ratio Rank
AORT Calmar Ratio Rank: 2121
Calmar Ratio Rank
AORT Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AGL vs. AORT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for agilon health, inc. (AGL) and Artivion, Inc. (AORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AGLAORTDifference

Sharpe ratio

Return per unit of total volatility

0.32

-0.57

+0.88

Sortino ratio

Return per unit of downside risk

1.94

-0.53

+2.48

Omega ratio

Gain probability vs. loss probability

1.26

0.91

+0.35

Calmar ratio

Return relative to maximum drawdown

0.65

-0.54

+1.19

Martin ratio

Return relative to average drawdown

0.97

-1.68

+2.65

AGL vs. AORT - Sharpe Ratio Comparison

The current AGL Sharpe Ratio is 0.32, which is higher than the AORT Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of AGL and AORT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AGLAORTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.32

-0.57

+0.88

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.37

-0.15

-0.22

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.34

0.08

-0.42

Drawdowns

AGL vs. AORT - Drawdown Comparison

The maximum AGL drawdown since its inception was -99.27%, roughly equal to the maximum AORT drawdown of -95.72%. Use the drawdown chart below to compare losses from any high point for AGL and AORT.


Loading charts...

Drawdown Indicators


AGLAORTDifference

Max Drawdown

Largest peak-to-trough decline

-99.27%

-95.72%

-3.55%

Max Drawdown (1Y)

Largest decline over 1 year

-86.98%

-57.13%

-29.85%

Max Drawdown (3Y)

Largest decline over 3 years

-98.50%

-57.13%

-41.37%

Max Drawdown (5Y)

Largest decline over 5 years

-99.27%

-66.35%

-32.92%

Max Drawdown (10Y)

Largest decline over 10 years

-72.00%

Current Drawdown

Current decline from peak

-91.98%

-57.13%

-34.85%

Average Drawdown

Average peak-to-trough decline

-67.76%

-56.64%

-11.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

58.05%

18.42%

+39.63%

Volatility

AGL vs. AORT - Volatility Comparison

agilon health, inc. (AGL) has a higher volatility of 82.04% compared to Artivion, Inc. (AORT) at 34.56%. This indicates that AGL's price experiences larger fluctuations and is considered to be riskier than AORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AGLAORTDifference

Volatility (1M)

Calculated over the trailing 1-month period

82.04%

34.56%

+47.48%

Volatility (6M)

Calculated over the trailing 6-month period

126.50%

42.95%

+83.55%

Volatility (1Y)

Calculated over the trailing 1-year period

172.82%

51.21%

+121.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

102.55%

44.88%

+57.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

101.67%

44.74%

+56.93%

Dividends

AGL vs. AORT - Dividend Comparison

Neither AGL nor AORT has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AGL
agilon health, inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AORT
Artivion, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.11%

Financials

AGL vs. AORT - Financials Comparison

This section allows you to compare key financial metrics between agilon health, inc. and Artivion, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20222023202420252026
1.42B
116.34M
(AGL) Total Revenue
(AORT) Total Revenue
Values in USD except per share items

AGL vs. AORT - Profitability Comparison

The chart below illustrates the profitability comparison between agilon health, inc. and Artivion, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%202220232024202520260
64.9%
Portfolio components
AGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, agilon health, inc. reported a gross profit of 0.00 and revenue of 1.42B. Therefore, the gross margin over that period was 0.0%.

AORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Artivion, Inc. reported a gross profit of 75.45M and revenue of 116.34M. Therefore, the gross margin over that period was 64.9%.

AGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, agilon health, inc. reported an operating income of 4.00M and revenue of 1.42B, resulting in an operating margin of 0.3%.

AORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Artivion, Inc. reported an operating income of 5.79M and revenue of 116.34M, resulting in an operating margin of 5.0%.

AGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, agilon health, inc. reported a net income of 29.97M and revenue of 1.42B, resulting in a net margin of 2.1%.

AORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Artivion, Inc. reported a net income of 1.42M and revenue of 116.34M, resulting in a net margin of 1.2%.


Frequently Asked Questions


AGL and AORT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AGL has higher volatility (82.04%) compared to AORT (34.56%). In terms of maximum drawdown, AGL dropped -99.27% vs AORT's -95.72%.

AGL currently has the higher Sharpe Ratio (0.32 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AGL and AORT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer